Literature DB >> 22632362

Ethnic differences in the clinical presentation of Graves' ophthalmopathy.

Chiaw-Ling Chng1, Lay Leng Seah, Daphne Hsu Chin Khoo.   

Abstract

Ethnic differences in a number of eye conditions have been described. The literature on ethnic differences in Graves' ophthalmopathy (GO) is limited. There is some evidence to suggest Asian patients with GO may manifest milder phenotypic features of GO, with less proptosis and evidence of extraocular muscle involvement and restriction. The reasons for these differences are likely to be multifactorial and include orbital and lid anatomy, genetic background and autoimmune responses including TSH -receptor antibodies. These differences should be kept in mind when evaluating and managing patients with GO.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22632362     DOI: 10.1016/j.beem.2011.10.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  12 in total

1.  Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review.

Authors:  S Seo; M Sánchez Robledo
Journal:  J Endocrinol Invest       Date:  2018-09-07       Impact factor: 4.256

2.  Graded decompression of orbital fat and wall in patients with Graves' orbitopathy.

Authors:  Kyou Ho Lee; Sun Young Jang; Sang Yeul Lee; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2014-01-21

3.  Are ethnicity, social grade, and social deprivation associated with severity of thyroid-associated ophthalmopathy?

Authors:  Matthew R Edmunds; Julie A Huntbach; Omar M Durrani
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2014 May-Jun       Impact factor: 1.746

4.  Dissecting the Genetic Susceptibility to Graves' Disease in a Cohort of Patients of Italian Origin.

Authors:  Angela Lombardi; Francesca Menconi; David Greenberg; Erlinda Concepcion; Marenza Leo; Roberto Rocchi; Michele Marinó; Mehdi Keddache; Yaron Tomer
Journal:  Front Endocrinol (Lausanne)       Date:  2016-03-08       Impact factor: 5.555

5.  Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.

Authors:  Qian Li; Huijing Ye; Yungang Ding; Guo Chen; Zhichang Liu; Jianan Xu; Rongxin Chen; Huasheng Yang
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

6.  Persistent hyperthyroidism and de novo Graves' ophthalmopathy after total thyroidectomy.

Authors:  Wei Lin Tay; Wann Jia Loh; Lianne Ai Ling Lee; Chiaw Ling Chng
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-10-13

7.  Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves' disease.

Authors:  Huiling Liew; Torquil Watt; Luo Nan; Alvin W K Tan; Yiong Huak Chan; Daniel Ek Kwang Chew; Rinkoo Dalan
Journal:  J Patient Rep Outcomes       Date:  2021-07-08

8.  Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.

Authors:  Young Jae Woo; Sun Young Jang; Tyler Hyung Taek Lim; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2015-07-21

9.  Severe Ophthalmological Complications of Thyroid Disease are Rare in Ibadan, Southwestern Nigeria: Results of a Pilot Study.

Authors:  Olufunmilola A Ogun; Jokotade O Adeleye
Journal:  Ophthalmol Eye Dis       Date:  2016-03-28

Review 10.  Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysis.

Authors:  Kah Hie Wong; Shi Song Rong; Kelvin K L Chong; Alvin L Young; Chi Pui Pang; Li Jia Chen
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.